Kent and Medway Cancer Research Network, Site #558

Gillingham

0 studies enrolling now · 1 studies all time

What they study most

Chronic Myeloid Leukemia

Studies at this site

• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) — Stopped early